All Stories

  1. Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets
  2. Standard PREanalytical Code Version 3.0
  3. Hospital-integrated Biobanking as a Service – The Interdisciplinary Bank of Biomaterials and Data Wuerzburg (ibdw)
  4. Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition
  5. The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable
  6. Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors
  7. A comparative analysis of the bistability switch for platelet aggregation by logic ODE based dynamical modeling
  8. Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways
  9. Response: platelet transcriptome and proteome--relation rather than correlation
  10. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling
  11. Dynamical modelling of prostaglandin signalling in platelets reveals individual receptor contributions and feedback properties
  12. A Boolean view separates platelet activatory and inhibitory signalling as verified by phosphorylation monitoring including threshold behaviour and integrin modulation
  13. Determination of ATP and ADP Secretion from Human and Mouse Platelets by an HPLC Assay
  14. Damit Blut nicht verklumpt
  15. The oligopeptide DT-2 is a specific PKG I inhibitor onlyin vitro, not in living cells
  16. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways
  17. Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
  18. Robust Workflow for iTRAQ-Based Peptide and Protein Quantification
  19. Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides
  20. The good, the bad, the ugly: Validating the mass spectrometric analysis of modified peptides
  21. Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
  22. Specific PKG inhibitors: do they really exist?
  23. Quantification of cAMP and cGMP analogs in intact cells: pitfals in enzyme immunoassays for cyclic nucleotides
  24. A protein phosphorylation-based assay for screening and monitoring of drugs modulating cyclic nucleotide pathways
  25. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of PKA from an NF-κB-IκB complex
  26. Phosphatidylserine surface expression and integrin αIIbβ3 activity on thrombin/convulxin stimulated platelets/particles of different sizes
  27. Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets: reply to a rebuttal
  28. Insulin inhibition of platelet-endothelial interaction is mediated by insulin effects on endothelial cells without direct effects on platelets
  29. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion
  30. Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase
  31. Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS
  32. Platelet NAD(P)H-oxidase-generated ROS production regulates  IIb 3-integrin activation independent of the NO/cGMP pathway
  33. Monitoring of Clopidogrel Action: Comparison of Methods
  34. Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase
  35. Dipyridamole Enhances NO/cGMP-Mediated Vasodilator-Stimulated Phosphoprotein Phosphorylation and Signaling in Human Platelets: In Vitro and In Vivo/Ex Vivo Studies
  36. Inhibition of platelet P2Y12 and α2A receptor signaling by cGMP-dependent protein kinase
  37. Inhibitors of platelet signal transduction as anti-aggregatory drugs
  38. Anti-aggregatory drugs: I. Platelet receptor antagonists
  39. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice
  40. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors
  41. The cGMP-dependent protein kinase-gene, protein, and function
  42. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.